Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2D in macrophages

FEBS Letters

Volumn 590, Issue 1, 2016, Pages 53-67

  Han, Xiaobin ^a   Li, Linqiang ^a   Yang, Jiancheng ^a   King, Gwendalyn ^b   Xiao, Zhousheng ^a   Quarles, Leigh Darryl ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

1,25(OH)2D; FGF 23; interferon gamma; Klotho; lipopolysaccharide; macrophages

Indexed keywords

ARGINASE 1; FIBROBLAST GROWTH FACTOR 23; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; JANUS KINASE; SOMATOMEDIN C; STAT1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN; 1 TERT BUTYL 3 [6 (3,5 DIMETHOXYPHENYL) 2 (4 DIETHYLAMINOBUTYLAMINO)PYRIDO[2,3 D]PYRIMIDIN 7 YL]UREA; ARG1 PROTEIN, MOUSE; ARGINASE; CALCITRIOL; CALCITRIOL RECEPTOR; FGFR1 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; HYBRID PROTEIN; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; RECOMBINANT PROTEIN;

ANALYSIS OF VARIANCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ELECTROPORATION; GENETIC TRANSCRIPTION; MACROPHAGE; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MOUSE; NONHUMAN; PARACRINE SIGNALING; POLARIZATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION SITE; VITAMIN METABOLISM; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MACROPHAGE ACTIVATION; METABOLISM; RAW 264.7 CELL LINE; REPORTER GENE; SIGNAL TRANSDUCTION;

ANIMALS; ARGINASE; CALCITRIOL; CELLS, CULTURED; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; GENES, REPORTER; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; PARACRINE COMMUNICATION; PROMOTER REGIONS, GENETIC; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RAW 264.7 CELLS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, CALCITRIOL; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 84955557590     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1002/1873-3468.12040     Document Type: Article

References (57)

1. Xiao Z, Dallas M, Qiu N, Nicolella D, Cao L, Johnson M, Bonewald L, and, Quarles LD, (2011) Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice. FASEB J 25, 2418 2432.
2. Liu S, Zhou J, Tang W, Jiang X, Rowe DW, and, Quarles LD, (2006) Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab 291, E38 E49.
3. Quarles LD, (2003) Evidence for a bone-kidney axis regulating phosphate homeostasis. J Clin Invest 112, 642-646.
4. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, and, Yamashita T, (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770 - 774.
5. Chen CD, Podvin S, Gillespie E, Leeman SE, and, Abraham CR, (2007) Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci USA 104, 19796 - 19801.
6. Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, et al. (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281, 6120 - 6123.
7. Chen CD, Tung TY, Liang J, Zeldich E, Tucker Zhou TB, Turk BE, and, Abraham CR, (2014) Identification of cleavage sites leading to the shed form of the anti-aging protein klotho. Biochemistry 53, 5579 - 5587.
8. van Loon EP, Pulskens WP, van der Hagen EA, Lavrijsen M, Vervloet MG, van Goor H, Bindels RJ, and, Hoenderop JG, (2015) Shedding of klotho by ADAMs in the kidney. Am J Physiol Renal Physiol 309, F359 - F368.
9. Chateau MT, Araiz C, Descamps S, and, Galas S, (2010) Klotho interferes with a novel FGF-signalling pathway and insulin/Igf-like signalling to improve longevity and stress resistance in Caenorhabditis elegans. Aging 2, 567 - 581.
10. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, et al. (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45 - 51.
11. Sugiura H, Yoshida T, Shiohira S, Kohei J, Mitobe M, Kurosu H, Kuro-o M, Nitta K, and, Tsuchiya K, (2012) Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis. Am J Physiol Renal Physiol 302, F1252 - F1264.
12. Hu MC, Shi M, Cho HJ, Adams-Huet B, Paek J, Hill K, Shelton J, Amaral AP, Faul C, Taniguchi M, et al. (2015) Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. J Am Soc Nephrol 26, 1290 - 1302.
13. Deng M, Luo Y, Li Y, Yang Q, Deng X, Wu P, and, Ma H, (2015) Klotho gene delivery ameliorates renal hypertrophy and fibrosis in streptozotocin-induced diabetic rats by suppressing the Rho-associated coiled-coil kinase signaling pathway. Mol Med Rep 12, 45 - 54.
14. Kovesdy CP, and, Quarles LD, (2013) Fibroblast growth factor-23: what we know, what we don't know, and what we need to know. Nephrol Dial Transplant 28, 2228 - 2236.
15. Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, et al. (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359, 584 - 592.
16. Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Bazzano LA, Xie D, Kretzler M, Nessel L, et al. (2012) Fibroblast growth factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol 7, 1155 - 1162.
17. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutierrez OM, Aguillon-Prada R, Lincoln J, Hare JM, et al. (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121, 4393 - 4408.
18. Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, MMKD Study Group, Kuen E, et al. (2007) Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 18, 2600 - 2608.
19. Isakova T, Wahl P, Vargas GS, Gutierrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, et al. (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79, 1370 - 1378.
20. Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol M, and HOST Investigators (2011) FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol 22, 1913 - 1922.
21. Scialla JJ, and, Wolf M, (2014) Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nat Rev Nephrol 10, 268 - 278.
22. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, Khan H, Baena CP, Prabhakaran D, Hoshen MB, et al. (2014) Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348, g1903.
23. Chonchol M, Greene T, Zhang Y, Hoofnagle AN, and, Cheung AK, (2015) Low vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO Study. Journal of the American Society of Nephrology: JASN. pii: ASN.2014101009. [Epub ahead of print].
24. Wang Y, and, Harris DC, (2011) Macrophages in renal disease. J Am Soc Nephrol 22, 21 - 27.
25. Epelman S, Liu PP, and, Mann DL, (2015) Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol 15, 117 - 129.
26. Kim M, Na W, and, Sohn C, (2013) Correlation between vitamin D and cardiovascular disease predictors in overweight and obese Koreans. J Clin Biochem Nutr 52, 167 - 171.
27. Liu S, Tang W, Zhou J, Stubbs JR, Luo Q, Pi M, and, Quarles LD, (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17, 1305 - 1315.
28. Zhang X, Zhou M, Guo Y, Song Z, and, Liu B, (2015) 1,25-Dihydroxyvitamin D3 promotes high glucose-induced M1 macrophage switching to M2 via the VDR-PPARgamma signaling pathway. BioMed Res Int 2015, 157834.
29. Hoover DL, and, Nacy CA, (1984) Macrophage activation to kill Leishmania tropica: defective intracellular killing of amastigotes by macrophages elicited with sterile inflammatory agents. J Immunol 132, 1487 - 1493.
30. Zhang X, Goncalves R, and, Mosser DM, (2008) The isolation and characterization of murine macrophages. Curr Protoc Immunol Chapter 14, Unit 14 1.
31. Jacobs ET, Van Pelt C, Forster RE, Zaidi W, Hibler EA, Galligan MA, Haussler MR, and, Jurutka PW, (2013) CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells. Cancer Res 73, 2563 - 2573.
32. Qin H, Wilson CA, Lee SJ, Zhao X, and, Benveniste EN, (2005) LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia. Blood 106, 3114 - 3122.
33. Cantorna MT, Zhu Y, Froicu M, and, Wittke A, (2004) Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 80, 1717S - 1720S.
34. Shalhoub V, Ward SC, Sun B, Stevens J, Renshaw L, Hawkins N, and, Richards WG, (2011) Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization. Calcif Tissue Int 89, 140 - 150.
35. Masuda Y, Ohta H, Morita Y, Nakayama Y, Miyake A, Itoh N, and, Konishi M, (2015) Expression of Fgf23 in activated dendritic cells and macrophages in response to immunological stimuli in mice. Biol Pharm Bull 38, 687 - 693.
36. Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, Gales B, Adams JS, Salusky IB, and, Hewison M, (2013) Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res 28, 46 - 55.
37. Adams JS, and, Hewison M, (2008) Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4, 80 - 90.
38. Saini RK, Kaneko I, Jurutka PW, Forster R, Hsieh A, Hsieh JC, Haussler MR, and, Whitfield GK, (2013) 1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6. Calcif Tissue Int 92, 339 - 353.
39. Quarles LD, (2011) The bone and beyond: -Dem bones’ are made for more than walking. Nat Med 17, 428 - 430.
40. Kundu R, Chain BM, Coussens AK, Khoo B, and, Noursadeghi M, (2014) Regulation of CYP27B1 and CYP24A1 hydroxylases limits cell-autonomous activation of vitamin D in dendritic cells. Eur J Immunol 44, 1781 - 1790.
41. Tagliabracci VS, Engel JL, Wiley SE, Xiao J, Gonzalez DJ, Nidumanda Appaiah H, Koller A, Nizet V, White KE, and, Dixon JE, (2014) Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis. Proc Natl Acad Sci USA 111, 5520 - 5525.
42. Stawowy P, Meyborg H, Stibenz D, Borges Pereira Stawowy N, Roser M, Thanabalasingam U, Veinot JP, Chretien M, Seidah NG, Fleck E, et al. (2005) Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis. Circulation 111, 2820 - 2827.
43. Andrukhova O, Slavic S, Smorodchenko A, Zeitz U, Shalhoub V, Lanske B, Pohl EE, and, Erben RG, (2014) FGF23 regulates renal sodium handling and blood pressure. EMBO Mol Med 6, 744 - 759.
44. Farrow EG, Davis SI, Summers LJ, and, White KE, (2009) Initial FGF23-mediated signaling occurs in the distal convoluted tubule. J Am Soc Nephrol 20, 955 - 960.
45. Zhou X, Chen K, Lei H, and, Sun Z, (2015) Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1/CC chemokine receptor 2-mediated inflammation. J Am Soc Nephrol 26, 121 - 132.
46. Gooz M, (2010) ADAM-17: the enzyme that does it all. Crit Rev Biochem Mol Biol 45, 146 - 169.
47. Kubin T, Poling J, Kostin S, Gajawada P, Hein S, Rees W, Wietelmann A, Tanaka M, Lorchner H, Schimanski S, et al. (2011) Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell 9, 420 - 432.
48. Dai B, David V, Martin A, Huang J, Li H, Jiao Y, Gu W, and, Quarles LD, (2012) A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model. PLoS ONE 7, e44161.
49. Meng XM, Nikolic-Paterson DJ, and, Lan HY, (2014) Inflammatory processes in renal fibrosis. Nat Rev Nephrol 10, 493 - 503.
50. Pan B, Liu G, Jiang Z, and, Zheng D, (2015) Regulation of renal fibrosis by macrophage polarization. Cell Physiol Biochem 35, 1062 - 1069.
51. Wang Y, Wang YP, Zheng G, Lee VW, Ouyang L, Chang DH, Mahajan D, Coombs J, Wang YM, Alexander SI, et al. (2007) Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 72, 290 â€" 299.
52. Ikezumi Y, Atkins RC, and, Nikolic-Paterson DJ, (2003) Interferon-gamma augments acute macrophage-mediated renal injury via a glucocorticoid-sensitive mechanism. J Am Soc Nephrol 14, 888 - 898.
53. Riek AE, Oh J, Darwech I, Moynihan CE, Bruchas RR, and, Bernal-Mizrachi C, (2014) 25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetes. J Steroid Biochem Mol Biol. 144 (Pt A), 172 - 179.
54. Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, Bhan I, Agarwal R, Zoccali C, Wanner C, et al. (2012) Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA 307, 674 - 684.
55. Touchberry CD, Green TM, Tchikrizov V, Mannix JE, Mao TF, Carney BW, Girgis M, Vincent RJ, Wetmore LA, Dawn B, et al. (2013) FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy. Am J Physiol Endocrinol Metab 304, E863 - E873.
56. Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M, and, Moe OW, (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22, 124 - 136.
57. Richter M, and, Walther LH, (2015) The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation. J Heart Lung Transplant 34, 1211 - 1214.